Insiders · CDNA

Fred E Cohen

Director at CareDx, Inc. (CDNA)

Fred E Cohen has filed 30 insider reports with the SEC since January 2021, as director at CareDx, Inc. (CDNA), director at Intellia Therapeutics, Inc. (NTLA) and director at Kyverna Therapeutics, Inc. (KYTX) and at 2 more companies. In the last 12 months Fred E Cohen bought $1.4M of stock on the open market. The latest filing, on November 4, 2026, reports gift at CareDx, Inc. (CDNA).

Filings
30
Companies
5
Bought on market
$1.4M
Sold on market
None

Companies where Fred E Cohen is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
CareDx, Inc. logo
CDNA
CareDx, Inc.
Director140,060$74.44Nov 4, 2026
Intellia Therapeutics, Inc. logo
NTLA
Intellia Therapeutics, Inc.
Director216,653$1.4M$9.35$9.77+4.5%Jun 10, 2026
Kyverna Therapeutics, Inc. logo
KYTX
Kyverna Therapeutics, Inc.
Director21,727$4.48May 29, 2026
Progyny, Inc. logo
PGNY
Progyny, Inc.
Director22,693$36.16Jun 3, 2025
UroGen Pharma Ltd. logo
URGN
UroGen Pharma Ltd.
Director$29.79Aug 8, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with Fred E Cohen.

Compare Fred E Cohen with

Other insiders at the same companies

Questions about Fred E Cohen

What is Fred E Cohen's role at CareDx, Inc.?
Fred E Cohen reports to the SEC as director at CareDx, Inc. (CDNA), according to the latest filing on November 4, 2026. Fred E Cohen has also filed as director at Intellia Therapeutics, Inc. (NTLA), director at Kyverna Therapeutics, Inc. (KYTX), director at Progyny, Inc. (PGNY) and director at UroGen Pharma Ltd. (URGN).
How many shares does Fred E Cohen own?
After the latest filing that states it, Fred E Cohen directly owned 140,060 shares of CareDx, Inc. (CDNA), 216,653 shares of Intellia Therapeutics, Inc. (NTLA), 21,727 shares of Kyverna Therapeutics, Inc. (KYTX) and 22,693 shares of Progyny, Inc. (PGNY). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Fred E Cohen bought or sold stock recently?
The most recent open-market purchase was on January 5, 2026: bought 150,000 shares of Intellia Therapeutics, Inc. (NTLA) for $1.4M at an average of $9.35.
How do I get alerts when Fred E Cohen files?
Follow Fred E Cohen on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Fred E Cohen filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Fred E Cohen (SEC CIK 0001339358). Totals count each trade once, skipping amendments whose original is on file, from Jan 22, 2021 on. View on SEC EDGAR